ACSS2 and cancer: Hypoxia in the tumor micro‐environment leads to up‐regulation of lipid metabolism‐related genes, such as ACSS2, which enhances lipid metabolism reprogramming through pathways like HMGCS1 mediated PI3K/AKT/mTOR, promoting the progression of various cancers, including pNETs.8